December 21, 2014 7:13 PM ET

Capital Markets

Company Overview of Pfizer Venture Investments

Executive Profile

William T. Burkoth

Executive Director , Pfizer Venture Investments
AgeTotal Calculated CompensationThis person is connected to 6 Board Members in 6 different organizations across 7 different industries.

See Board Relationships
----

Background

Mr. William T. Burkoth, also known as Bill serves as Executive Director of Pfizer Venture Investments. He was a Senior Director at the firm. Mr. Burkoth joined Pfizer Venture Investments in 2004 and has played an instrumental role in numerous new venture investments including Avid Radiopharmaceuticals (acquired by Eli Lilly), Evolution Benefits (acquired by Genstar Capital), and HandyLab (acquired by Becton Dickinson). He worked in Business Development at Galileo Pharmaceuticals ...

Corporate Headquarters

235 East 42nd Street
New York, New York 10017-5755

United States

Phone: 212-733-2323
Fax: 212-573-7851

Board Members Memberships

Director
Former Director
Director
Director
Director
Director
2014-Present
Director

Education

MBA 2011
Columbia Business School
BS
Whitman College

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Pfizer Venture Investments, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.